top of page
Pfizer COVID-19 Oral Antiviral
Tue, Apr 26
|WebEx
Learn about the Pfizer antiviral nirmatrelvir/ritonavir combination sold under the brand name Paxlovid. Speakers are Shoaib Khan, MD, Field Medical Director, North American Medical Affairs, Pfizer; and Tracy R. Wilson, DNP, MSN.Ed., RN, FNP-C, Field Medical Director, Southwest Region, Pfizer.
Registration is closed
See other events
Time & Location
Apr 26, 2022, 6:00 PM – 7:00 PM
WebEx
Guests
About the event
Nirmatrelvir is an antiviral medication developed by Pfizer which acts as an orally active 3C-like protease inhibitor. It is part of the nirmatrelvir/ritonavir combination sold under the brand name Paxlovid.
Attendees may have to download WebEx to view the presentation.
Information from Pfizer does not constitute endorsement or recommendation by MCMS.
bottom of page